No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
NUZ Neurizon Therapeutics Ltd
- 0.162
- +0.002+1.25%
20min DelayTrading Jan 14 10:59 AET
79.75MMarket Cap-7.71P/E (Static)
0.162High0.160Low26.05KVolume0.160Open0.160Pre Close4.21KTurnover0.24552wk High0.01%Turnover Ratio492.31MShares0.16052wk Low-0.021EPS TTM56.86MFloat Cap0.245Historical HighLossP/E (Static)350.97MShs Float0.160Historical Low-0.021EPS LYR1.25%Amplitude--Dividend TTM7.71P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Neurizon's ALS Drug Candidate Receives Orphan Medicinal Product Designation in Europe; Shares Down 3%
Neurizon Reports Positive Results From Preclinical Study of Amyotrophic Lateral Sclerosis Treatment Candidate; Shares Fall 4%
Neurizon's Fast-track Application for Flagship Drug in Europe Received 'Positively'
PharmAust Changes Name to Neurizon Therapeutics
Heat List
AU
Overall
Symbol
Price
% Chg
No Data